Home | Medical-Newswire.Com:
(Medical-NewsWire.com, November 13, 2017 ) According to Publisher, the Global Defibrillators market is accounted for $10.61 billion in 2015 and is expected to reach $19.31 billion by 2022 growing at a CAGR of 8.9%. The defibrillation is a procedure comprising of delivering an electric shock to the heart, which depolarizes heart muscles and restores its normal electric impulse during cardiac arrest. Technological advancement of defibrillators, geriatric population with high risk of target diseases and increasing number of training and awareness programs across the globe are proliferating the market. However, product failures & recalls and lack of awareness about sudden cardiac arrest (SCA) are the factors inhibiting the market.
For more information about this report: http://www.reportsweb.com/defibrillators-global-market-outlook-2016-2022
Wearable Cardioverter Defibrillators (WCDS) in External Defibrillators segment is expected to gain its momentum through dominating the market, owing to its user-friendly nature and wearable techniques. Hospitals, Clinics, & Cardiac Centers segment is expected to throttle the market in order to its necessity in healthcare. Asia Pacific is accounted for the largest share of the market attributing to large number of healthcare reforms, high prevalence of heart failures, and increased focus of key players on developing technologically advanced cost-effective defibrillators.
Some of the key players of the Defibrillators market include Access Cardio Systems, BIOTRONIC SE & Co. KG, Boston Scientific Corporation, Cardiac Science Corporation, Defibtech LLC, Fukuda Denshi USA Inc., GE Healthcare, HeartSine Technologies, Koninklijk, Philips N.V., Medtronic Inc., Metrax, Nihon Kohden corporation, Philips Healthcare, Physio-Control Inc., Progetti S.R.I, Schiller AG, Sorin Group, St. Jude Medical Inc., Welch Allyn and ZOLL Medical Corporation.
- Alternate Care Markets
- Home Care
- Hospitals, Clinics, & Cardiac Centers
- Public Access Markets
Product Types Covered:
- Implantable Cardioverter Defibrillators (ICDS)
o Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS)
o Transvenous Implantable Cardioverter Defibrillators (T-ICDS)
Biventricular ICDS/Cardiac Resynchronization Therapy Defibrillators
- External Defibrillators
o Automated External Defibrillators (AEDS)
Semi-Automated External Defibrillators
Fully Automated External Defibrillators
o Manual External Defibrillators
o Wearable Cardioverter Defibrillators (WCDS)
Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001564987/sample
- North America
o Rest of Europe
- Asia Pacific
o New Zealand
o Rest of Asia Pacific
- Rest of the World
o Middle East
o South Africa
What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
9.1 Access Cardio Systems
9.2 BIOTRONIC SE & Co. KG
9.3 Boston Scientific Corporation
9.4 Cardiac Science Corporation
9.5 Defibtech LLC
9.6 Fukuda Denshi USA Inc.
9.7 GE Healthcare
9.8 HeartSine Technologies
9.9 Koninklijke Philips N.V.
9.10 Medtronic Inc.
9.12 Nihon Kohden corporation
9.13 Philips Healthcare
9.14 Physio-Control Inc.
9.15 Progetti S.R.I
9.16 Schiller AG
9.17 Sorin Group
9.18 St. Jude Medical Inc.
9.19 Welch Allyn
9.20 ZOLL Medical Corporation
Inquire before Buying at http://www.reportsweb.com/inquiry&RW0001564987/buying